Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
AstraZeneca
University of Alberta
University of California, Irvine
Boehringer Ingelheim
Emory University
National Institutes of Health Clinical Center (CC)
European Organisation for Research and Treatment of Cancer - EORTC
Centre Oscar Lambret
Istanbul University
Asan Medical Center
M.D. Anderson Cancer Center